Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace You Might Also Like Incysus Announces Formation Of Scientific Advisory Board August 23, 2017 5 Massachusetts Biotechs That Tanked More Than 60% in 2017 January 1, 2018 Vancouver???s Zymeworks to Hire an Additional 45 Employees by the End of 2017 May 30, 2017
